| Target Price | HK$23.46 |
| Price | HK$19.53 |
| Potential |
20.12%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target Sinopharm Group 2026 .
The average Sinopharm Group target price is HK$23.46.
This is
20.12%
register free of charge
HK$25.94
32.80%
register free of charge
HK$18.83
3.60%
register free of charge
|
|
| A rating was issued by 22 analysts: 15 Analysts recommend Sinopharm Group to buy, 7 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Sinopharm Group stock has an average upside potential 2026 of
20.12%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | 647.11 | 661.26 |
| 2.02% | 2.19% | |
| EBITDA Margin | 3.35% | 3.42% |
| 16.88% | 1.94% | |
| Net Margin | 1.21% | 1.27% |
| 20.53% | 5.30% |
18 Analysts have issued a sales forecast Sinopharm Group 2025 . The average Sinopharm Group sales estimate is
This results in the following potential growth metrics:
17 Analysts have issued an Sinopharm Group EBITDA forecast 2025. The average Sinopharm Group EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
18 Sinopharm Group Analysts have issued a net profit forecast 2025. The average Sinopharm Group net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | 2.50 | 2.68 |
| 22.12% | 7.20% | |
| P/E | 7.28 | |
| EV/Sales | 0.19 |
18 Analysts have issued a Sinopharm Group forecast for earnings per share. The average Sinopharm Group EPS is
This results in the following potential growth metrics and future valuations:
Sinopharm Group...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


